Personal Protective Equipment Use and Hazardous Drug Spills among Ambulatory Oncology Nurses: Results from a Mailed Survey
Published Date:Jan 06 2017
Source:Oncol Nurs Forum. 44(1):60-65.
Pubmed Central ID:PMC5225785
Funding:R01 OH010582/OH/NIOSH CDC HHS/United States
T42 OH008455/OH/NIOSH CDC HHS/United States
To examine patterns and organizational correlates of personal protective equipment (PPE) use and hazardous drug spills.
Cross-sectional mailed survey.
Ambulatory practices in California, Georgia, and Michigan.
252 Oncology Nursing Society members who administer hazardous drugs.
Bivariate and multivariable regression analyses.
Main Research Variables
Outcomes were PPE use and hazardous drug spills. Covariates included nursing workloads, nurses’ practice environments, and barriers to PPE use.
26% reported a recent drug spill. 90% wore only one pair of chemotherapy-tested gloves. Increased PPE use was significantly associated with nurse participation in practice affairs (β = 0.25, 95% CI 0.10 to 0.41), non-private ownership (β= 0.37, 95% CI 0.10 to 0.64), increased nursing workloads (β = 0.03, 95% CI 0.01 to 0.04), and fewer barriers to PPE use (β = 0.65, 95% CI 0.36 to 0.93). Spills were significantly associated with less favorable manager leadership and support (OR 0.68, 95% CI 0.47 to 0.98), and higher workloads (OR 1.03, 95% CI 1.01 to 1.06).
Drug spills occur often in ambulatory settings. PPE use remains low and barriers to use persist. Higher workloads are associated with both lower PPE use and more spills.
Managers should monitor and correct aberrant workloads and assure PPE is available and staff are trained.
1) Workloads are an important factor to consider in reducing hazardous drug exposures. 2) Nurses report substantial barriers to exposure prevention, including absence of equipment and lack of training. 3) Educational interventions are needed to improve use of PPE and reduction in hazardous drug exposures
You May Also Like: